Research reading
Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale demand and the Norway (NOR) to Denmark (DNK) lane
Denmark (DNK) reported $369.0M of medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale imports in 2023. Norway (NOR) accounted for 0.1% of the observed market and reported $438.2K in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +6.8% buyer growth and +8.5% exporter growth. The page separates reported values from projections and indicators.
